BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Vamil Divan does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 SVRASavara Inc | Buy | $8.00 | May 2025 | +111.2% | Miss |
 ANIPANI Pharmaceuticals Inc | Buy | $86.00 | May 2025 | +15.7% | Hit |
 VALNValneva SE ADR | Buy | $14.00 | May 2025 | −23.7% | Miss |
 UNCYUnicycive Therapeutics Inc | Buy | $6.00 | Apr 2025 | +5.8% | Miss |
| ANIPANI Pharmaceuticals Inc | Buy | $86.00 | Apr 2025 | +5.2% | Hit |
 ASMBAssembly Biosciences Inc | Buy | $31.00 | Mar 2025 | +162.4% | Hit |
 ABSIAbsci Corp | Buy | $10.00 | Mar 2025 | −2.5% | Miss |
 PFEPfizer Inc | Buy | — | Mar 2025 | +9.9% | — |
| ANIPANI Pharmaceuticals Inc | Buy | $86.00 | Mar 2025 | +18.9% | Hit |
| ABSIAbsci Corp | Buy | $10.00 | Dec 2024 | −1.1% | Miss |
| ABSIAbsci Corp | Buy | $10.00 | Oct 2024 | −3.0% | Miss |
 PROKProKidney Corp. | Buy | $6.00 | Sep 2024 | +0.1% | Hit |
| ANIPANI Pharmaceuticals Inc | Buy | $77.00 | Apr 2024 | +6.6% | Miss |
 SCYXScynexis Inc | Buy | $9.00 | Apr 2023 | −70.7% | Miss |
| SCYXScynexis Inc | Buy | $8.00 | Mar 2023 | −21.6% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.